A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Coronary Artery Disease
Interventions
DEVICE

Cleerly Labs and Cleerly ISCHEMIA

Participants in the coronary plaque-based care arm will have CCTA at baseline. CCTA images will be redacted and uploaded to Cleerly, interpreted using Cleerly Labs and Cleerly ISCHEMIA, and archived.

Trial Locations (21)

12211

RECRUITING

Capital Cardiology Associates, Albany

20715

RECRUITING

Flourish- Bowie, Bowie

23225

RECRUITING

Chippenham and Johnston Willis Hospitals, Richmond

32789

RECRUITING

Flourish Research, Winter Park

33614

RECRUITING

Tampa Cardiovascular Interventions and Research, Tampa

36608

RECRUITING

Cardiology Associates of Mobile, Mobile

37920

RECRUITING

The University of Tennessee Medical Center, Knoxville

41017

RECRUITING

Saint Elizabeth Medical Center, Edgewood

45221

RECRUITING

University of Cincinnatti, Cincinnati

50266

RECRUITING

MercyOne Des Moines Medical Center, West Des Moines

60201

RECRUITING

Endeavor Health Clinical Operations, Evanston

63044

RECRUITING

St. Louis Heart and Vascular, Bridgeton

70112

RECRUITING

Tulane University, New Orleans

73120

RECRUITING

Oklahoma Cardiovascular Research Group, Oklahoma City

76104

RECRUITING

Medical City Fort Worth Hospital, Fort Worth

80021

RECRUITING

Intermountain Health Saint Joseph Hospital, Broomfield

90255

RECRUITING

Valiance Clinical Research- Huntington Park, Huntington Park

90502

RECRUITING

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance

91356

RECRUITING

Valiance Clinical Research- Tarzana, Tarzana

91911

RECRUITING

Cardiovascular Institute of San Diego, San Diego

08822

RECRUITING

Advanced Heart and Vascular Institute of Hunterdon, Flemington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cleerly, Inc.

INDUSTRY

NCT06713239 - A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD | Biotech Hunter | Biotech Hunter